Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hookipa Biotech AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10682
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hookipa Biotech AG (Hookipa) is a biotechnology company that develops vaccines and next-generation immunotherapeutics for the prevention and treatment of cancer and infectious diseases. The company’s lead product candidate include HB101 vaxwave, a vaccine under development for immunization against cytomegalovirus; HB201 for the treatment of human papilloma virus, and others. It uses its proprietary immunotherapy technology vaxwave that is used to develop a new class of cancer immunotherapeutics and vaccines. Hookipa’s vaxwave uses a replication-defective viral vector to develop prophylactic and therapeutic vaccines to treat cancer and infectious diseases. The company’s vaxwave-based immunotherapy can be applied repeatedly to enhance the immune system against diseases where B-cell and T-cell immune responses are required. Hookipa is headquartered in Vienna, Austria.

Hookipa Biotech AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Licensing Agreements 14
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG – Key Competitors 15
Hookipa Biotech AG – Key Employees 16
Hookipa Biotech AG – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Oct 18, 2017: Dr. Jan van de Winkel Joins Hookipa as Chairman of its Board of Directors 18
Apr 19, 2017: Reinhard Kandera Appointed Chief Financial Officer of Hookipa Biotech 19
Apr 19, 2017: Hookipa Biotech appoints CFO 20
Product News 21
May 26, 2017: Hookipa Biotech Announces Nature Communications Publication Showing TheraT Turns Cold Tumors Hot 21
05/15/2018: New Insights into Hookipa’s TheraT Replicating Viral Vector Platform Published in Immunity 22
03/06/2017: Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech 23
01/09/2017: Hookipa Biotech Announces Publication in Clinical and Vaccine Immunology Highlighting Vaxwave as an Effective Viral Vector for Vaccination against Congenital Cytomegalovirus Infections 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Key Facts 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Deals By Therapy Area, 2012 to YTD 2018 8
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Hookipa Biotech Raises USD58.8 Million in Series C Financing 10
Hookipa Biotech Raises US$27 Million In Series B Financing 12
Gilead Sciences Enters into Licensing Agreement with Hookipa Biotech 14
Hookipa Biotech AG, Key Competitors 15
Hookipa Biotech AG, Key Employees 16

List of Figures
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hookipa Biotech AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Hookipa Biotech AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Myriad Group AG:企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Post Holdings, Inc.:戦略・SWOT・企業財務分析
    Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Post Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • The Toro Company:企業の戦略・SWOT・財務情報
    The Toro Company - Strategy, SWOT and Corporate Finance Report Summary The Toro Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hudson’s Bay Company:企業の戦略・SWOT・財務情報
    Hudson's Bay Company - Strategy, SWOT and Corporate Finance Report Summary Hudson's Bay Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Universal Biosensors Inc (UBI):企業の財務・戦略的SWOT分析
    Universal Biosensors Inc (UBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Hotel Croatia Cavtat:企業の戦略・SWOT・財務分析
    Hotel Croatia Cavtat - Strategy, SWOT and Corporate Finance Report Summary Hotel Croatia Cavtat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • WESCO International, Inc.:企業の戦略・SWOT・財務情報
    WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report Summary WESCO International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Danieli & C. Officine Meccaniche SpA:企業の戦略・SWOT・財務分析
    Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report Summary Danieli & C. Officine Meccaniche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bidstack Group Plc (BIDS):企業の財務・戦略的SWOT分析
    Bidstack Group Plc (BIDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • National Bank of Kuwait S.A.K.:戦略・SWOT・企業財務分析
    National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report Summary National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • QBE Insurance Group Limited:企業のM&A・事業提携・投資動向
    QBE Insurance Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's QBE Insurance Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bank of Cyprus Public Company Ltd:企業の戦略・SWOT・財務情報
    Bank of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Cyprus Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Advaxis Inc (ADXS):企業の財務・戦略的SWOT分析
    Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NSK Ltd.:企業の戦略・SWOT・財務情報
    NSK Ltd. - Strategy, SWOT and Corporate Finance Report Summary NSK Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Volpara Health Technologies Ltd (VHT):医療機器:M&Aディール及び事業提携情報
    Summary Volpara Health Technologies Ltd (Volpara Health) is a medical equipment company that develops and manufactures breast imaging analytics and analysis products that improve clinical decision-making and early detection of breast cancer. The company offers clinically-validated software products …
  • Pharmacosmos AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Vitol Holding BV:企業の戦略的SWOT分析
    Vitol Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Allison Transmission Holdings Inc
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆